Sedation at the end of life outside specialist palliative care - An exploratory mixed methods study on practices and challenges in Germany - SedEol
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,194
研究概览
简要总结
The use of sedatives overall and the use of sedatives with a continuous effect was significantly more frequently in hospitals than in nursing homes: 63% of patients received sedatives overall and 50% with a continuous effect in hospitals; in nursing homes, 21% of residents received sedatives overall and 9% with a continuous effect. Midazolam was administered most frequently in hospitals and lorazepam in nursing homes. Around a third of patients/residents were administered sedatives with a continuous effect without documentation of an indication. The age of the patients/residents, the setting, the documentation of the term "palliative" (hospital only) and the inclusion of specialised palliative care (hospital only) were found to be significant influencing factors for the use of sedatives.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Part I (retrospective case notes review): Adult patients who died in participating centres between 2015 and 2017
- •Part II: Physicians and nurses working in the participating centres + additional selected physicians and nurses from different hospital departments and general practitioners, who care for patients in nursing homes, from different sites in Germany, who have experience in caring for dying people.
排除标准
- •Part I: < 18 years
- •Part II: unable to speak sufficient German; < 18 years